Jun 22, 2020
Agenus Cell Therapy and Checkpoint Antibody Combinations Show Curative Preclinical Efficacy at AACR 2020
Jun 19, 2020
Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China
Jun 10, 2020
PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I
Jun 10, 2020
AbbVie and Genmab Announce Broad Oncology Collaboration
May 28, 2020
Clinical Studies & Research Progressing for Finding Cure for Glioblastoma
May 14, 2020
Agenus NextGen CTLA-4 Antibody (AGEN1181) Data to be Presented at ASCO
Apr 21, 2020
Allterum Therapeutics closes $2.9 million CPRIT award to develop novel NCI technology for treating pediatric leukemia, initiates drug manufacturing scale-up with FujiFilm Diosynth
Apr 17, 2020
SAB Biotherapeutics Advances Therapeutic for COVID-19 in Partnership with Department of Defense and BARDA
Apr 09, 2020
Biohaven Receives FDA May Proceed Letter to Begin Phase 2 Trial of Intranasal Vazegepant to Treat Lung Inflammation After COVID-19 Infection
Apr 05, 2020
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
Mar 12, 2020
AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
Mar 12, 2020
Agenus Receives Fast Track Designation for Balstilimab & Zalifrelimab in Advanced Cervical Cancer
Feb 20, 2020
Agenus Announces Positive Interim Data from Balstilimab and Zalifrelimab Clinical Trials in Second-Line Cervical Cancer
Feb 20, 2020
Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial
Feb 06, 2020
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours
Jan 08, 2020
Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer
Jan 08, 2020
Agenus Commences Phase 1 trial with AGEN1223
Dec 09, 2019
CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody
Nov 12, 2019
Agenus to Host R&D Day November 15, 2019
Nov 11, 2019
Agenus receives $10M from UroGen Pharma for rights to Zalifrelimab (CTLA-4) for intravesical treatment of urinary tract cancers